Citation tools
"Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant 225Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study." Journal of Nuclear Medicine
64.2
(2023):
211-218.
Web. 24 April. 2025.